Manystrains of zygomycetes and actinomycetes were found to convert milbemycin A4 (la) to 1 3/Miydroxymilbemycin A4 (lb). Amongthese strains, Cunninghamella echinulata ATCC9244 had the mostefficient 13/?-hydroxylation ability on milbemycins.In the conversion of milbemycinA3 (2a), 29-hydroxymilbemycin A4 (4a), and 30-hydroxymilbemycin A4 (5a) with this strain, only 13/Miydroxylated products were obtained. On the other hand, starting from milbemycin A4 (la) and 5-ketomilbemycin A4 5-oxime (6a), 1 3/7,24-and 1 3/?,30-dihydroxy derivatives were also isolated along with 1 3/Miydroxylated products. Similarly, conversion of milbemycin D (3a) and LL-F28249a (8a) gave 13/?-and 28-hydroxy derivatives (8b and 8c).
Milbemycins are a family of sixteen-membered macrolides produced by Streptomyces hygroscopicus subsp. aureolacrimosus1 "^, and they exhibit potent antiparasitic and pesticidal activities. Similar structural features and biological activities have also been reported for avermectin4) and LL-F282495) isolated from culture broths of Streptomyces avermitilis and Streptomyces cyaneogriseus subsp. noncyanogenus, respectively.
In a previous paper6), we reported that microbial conversion ofmilbemycin A4 (la), for the preparation of new derivatives that could be used as intermediates in new-compoundsynthesis or as metabolite reference standards in animal metabolism studies, resulted in efficient hydroxylation at the C-30 position ofmilbemycins and related compounds. During these screening studies we found that a variety of microbial strains converted milbemycin A4 (la) to the 1 3/?-hydroxy derivative (lb). Ramos Tombo et al. have recently demonstrated microbial conversion of milbemycin derivatives7*. They described 1 3/?-hydroxylation and 14,15-epoxydation of milbemycins A3 (2a), A4 (la), and D (3a) by the culture of Streptomyces violascens ATCC31560, and 13/?-hydroxylation of 5-ketomilbemycin A4 5-oxime (6a) by the microorganism in the presence of dimethyl sulfoxide. This prompted us to describe herein our independent results.
The present paper deals with 1 3/?-hydroxylation ofmilbemycin A4 (la) by many strains ofzygomycetes and actinomycetes, and with a variety of hydroxylated derivatives of milbemycins and related compounds ( Fig. 1) produced by Cunninghamella echinulata ATCC9244 belonging to zygomycetes, the organism that showed the most potent hydroxylation activity on milbemycin A4 (la) in our study.
Materials and Methods

Materials
Milbemycins A3 (2a)1}, A4 (la)1}, D (3a)3), 30-hydroxymilbemycin A4 (5a)6), and LL-F28249a (8a)5) were Ri  R2  R3  R4  R5  R6   la  CH2CH3  H  H  H  H  OH  2a  CH3  H  H  H  H  OH  3a  CH(CH3)2  H  H  H  H  OH  4a  CH2CH3  H  H  OH  H  OH  5a  CH2CH3  OH  H  H  H  OH  6a  CH2CH3  H  H  H  NOH  7a  CH2CH3  '  H  H  H  O   8a c\cH3) = CHCH(CH3)2 H OH H H OH isolated as described previously. 29-Hydroxymilbemycin A4 (4a)8), 5-ketomilbemycin A4 5-oxime (6a)9), and 5-ketomilbemycin A4 (7a)3' 9) were prepared from milbemycin A4 (la) according to literature procedures.
13/?,30-Dihydroxymilbemycin A4 (le), which was isolated as described previously6), and 13/?-hydroxymilbemycins A3 (2b), A4 (lb), and D (3b)10), which were synthesized, were used as authentic reference compounds. Microorganisms Microorganisms were obtained from various culture collections and were also isolated from soil samples.
Culture Medium MYmedium consisted of glucose 1.0%, Polypepton (Daigo Nutritive Chemicals) 0.5%, yeast extract (Difco) 0.3%, and malt extract (Difco) 0.3%, pH 6.3-6.5.
Microbial Conversion of Milbemycin A4 (la) Each microbial culture was inoculated into 100-ml Erlenmeyer flasks containing 20 ml of MYmedium. The flasks were incubated at 200~220rpmon a rotary shaker for a period of 2 to 3 days at 26°C for fungi, and at 28°C for actinomycetes. Then milbemycin A4 (la) (5% (w/v) in 1,4-dioxane) was added to a final concentration of 500 fig/ml, and cultivation was continued for additional 7 days.
TLC and HPLCAnalysis
The culture broths were extracted with EtOAc. The extracts were examined by TLC (Merck Art. No. 5715: EtOAc) . Developed chromatograms were detected under 254nm UVlight or by spraying with ammonium molybdate (10% (w/v) in EtOH), followed by warming on a hot plate. The analytical HPLCwas performed using a Nova pak C18 (Waters, 8 mmx Isolation of Conversion Products from Milbemycin A4 (la) C. echinulata ATCC9244 was cultured in ten 500-ml Erlenmeyer flasks containing 100ml of MY medium at 26°C on a rotary shaker (200~220rpm). After 3 days cultivation, milbemycin A4 (la) (5% (w/v) in 1,4-dioxane) was added to a final concentration of 500/ig/ml, and cultivation was continued subsequently for seven additional days. Then the culture broth was filtered and the filtrate was extracted with EtOAc (three times). The mycelium was extracted with 80% MeOH.The MeOHextract was then evaporated and the resulting aqueous solution was extracted with EtOAc(three times). The combined EtOAcextracts were evaporated and chromatographed on silica gel (20~90%EtOAcin rc-hexane as eluent) to give the 13/?-hydroxy derivative (lb) and a mixture of two more-polar minor products. Those two minor products were further purified by preparative TLC (Merck Art. No. 5744: EtOAc).
Results and Discussion
Microbial Conversion of Milbemycin A4 (la) to 1 3/?-Hydroxymilbemycin A4 (lb) Manystrains of zygomycetes and actinomycetes from the type culture collections, and actinomycetes from soil isolation, were found to be capable of converting milbemycin A4 (la) to the 13/?-hydroxy derivative (lb). Representative microorganisms that converted milbemycin A4 (la) to the 13/?-hydroxy derivative (lb) are shown in Table 1 , along with the conversion efficiency determined by the aid of HPLC analysis. According to HPLCanalyses of converting products, C. echinulata ATCC9244 seemed to be the most efficient 13/Miydroxylating strain, and it produced two more-polar minor products besides the 13/?-hydroxylated product. Therefore, this fungus was employed in the following preparative-scale study for characterizing converted products and was used for subsequent work. +1   +2  +1  +3  +1  +2  +1  +3  +1  +3  +1  +1  +3  +1  +1  +1  +2  +3  +3 +1 :0.5-10%, +2: 10-30%, +3: more than 30% (HPLC analysis). 5-ketomilbemycin A4 (7a), and LL-F28249a (8a) were examined using a similar method as for milbemycin A4 (la). The results are summarized in Table 2 . C. echinulata ATCC9244 was able to convert most of these compounds to corresponding 13/Miydroxy derivatives, and some other hydroxy compounds. The exception was 5-ketomilbemycin A4 (7a). No conversion product from 5-ketomilbemycin A4 (7a) was detected. Therefore, the hydroxyl group of the C-5 position of milbemycin A4 (la) may be essential for the hydroxylations by C. echinulata ATCC9244. Chromatograms of the hydroxylation products are summarized in Table 3 . The spectral evidence in support of the identification of conversion products is given below. The structures of conversion products are shownin Fig. 2 . Production of the hydroxylated derivatives ofmilbemycins A3 (2a), A4 (la), and D (3a), were estimated quantitatively as a function of cultivation time. These 13/?-hydroxylated derivatives and 28-hydroxymilbemycin D (3c) persisted at constant levels from 4 days until the end of culture at 8days. Amongthem, 13/Miydroxymilbemycin A4 (lb) was produced most efficiently. Hydroxylation products at the C-24 or C-30 position were also obtained as 13/?,24-or 13/?,30-dihydroxy compounds from milbemycin A4 (la) and 5-ketomilbemycin A4 5-oxime (6a). From the time course profile of milbemycin A4 (la), these compounds were detected 1 day or 2 days following the production of the 13^-hydroxy derivative (lb). However, it can not be determined whether these compounds arise from 13/?-hydroxymilbemycin A4 (lb) or from the preformed 24-or 30-hydroxymilbemycin A4 (Id or le). Both the 1 30-and 28-hydroxy derivatives were obtained from milbemycin D (3a) and LL-F28249a (8a). A trace amount of 28-hydroxymilbemycin A4 was also detected by HPLC(data not shown). Variation in the yield of 13)5-and 28-hydroxy derivatives suggested that the rather large bulk of the C-25 side chain caused the decrease in the yield of 13/?-hydroxy derivatives and the increase in the yield of 28-hydroxy derivatives. The proposed bioconversion pathway of milbemycin A4 (la) by C. echinulata ATCC9244 is presented in Fig. 3 . Compared with milbemycins, the hydroxylated compounds newly obtained in this study did not improve acaricidal activities. Ramos Tomboet al. reported 1 3j5-hydroxylation and 14, 1 5-epoxydation ofmilbemycins by S. violascens In summation, the research described above establishes efficient microbial hydroxylation of milbemycins and related compounds at the C-13/? position by C. echinulata ATCC9244. Further work is under way to thoroughly define the scope of the microbial conversions of milbemycins and related compounds.
Physico-chemical Properties
The *H NMRspectral data are listed in Table 4 . 
